NASDAQ: ABCL
Abcellera Biologics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABCL

Based on 3 analysts offering 12 month price targets for Abcellera Biologics Inc

Min Forecast
$5.00+31.58%
Avg Forecast
$8.33+119.29%
Max Forecast
$10.00+163.16%

Should I buy or sell ABCL stock?

Based on 3 analysts offering ratings for Abcellera Biologics Inc.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ABCL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ABCL as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their ABCL stock forecasts and price targets.

ABCL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-16
lockedlocked$00.00+00.00%2025-04-16
lockedlocked$00.00+00.00%2025-02-28

1 of 1

ABCL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABCL$3.80$8.33+119.29%Strong Buy
NTLA$10.74$32.67+204.16%Buy
NVAX$6.80$6.50-4.41%Strong Sell
GPCR$20.37$67.80+232.92%Strong Buy
MNKD$3.60N/AN/A

Abcellera Biologics Stock Forecast FAQ

Is Abcellera Biologics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ABCL) stock is to Strong Buy ABCL stock.

Out of 3 analysts, 3 (100%) are recommending ABCL as a Strong Buy, 0 (0%) are recommending ABCL as a Buy, 0 (0%) are recommending ABCL as a Hold, 0 (0%) are recommending ABCL as a Sell, and 0 (0%) are recommending ABCL as a Strong Sell.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.

What is ABCL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ABCL price target, the average ABCL price target is $8.33, with the highest ABCL stock price forecast at $10.00 and the lowest ABCL stock price forecast at $5.00.

On average, Wall Street analysts predict that Abcellera Biologics's share price could reach $8.33 by May 16, 2026. The average Abcellera Biologics stock price prediction forecasts a potential upside of 119.29% from the current ABCL share price of $3.80.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.